S&P 500   3,091.72 (+0.15%)
DOW   27,689.89 (-0.01%)
QQQ   201.39 (+0.21%)
CGC   19.26 (-5.17%)
BABA   186.46 (-0.13%)
GE   11.42 (+0.62%)
T   39.16 (-0.53%)
F   9.07 (-0.22%)
ACB   3.58 (-1.10%)
PRI   129.75 (+0.40%)
BAC   33.06 (-0.36%)
DIS   138.45 (+1.25%)
S&P 500   3,091.72 (+0.15%)
DOW   27,689.89 (-0.01%)
QQQ   201.39 (+0.21%)
CGC   19.26 (-5.17%)
BABA   186.46 (-0.13%)
GE   11.42 (+0.62%)
T   39.16 (-0.53%)
F   9.07 (-0.22%)
ACB   3.58 (-1.10%)
PRI   129.75 (+0.40%)
BAC   33.06 (-0.36%)
DIS   138.45 (+1.25%)
Log in

VolitionRX Stock Price, Forecast & Analysis (NYSEAMERICAN:VNRX)

$5.29
-0.21 (-3.82 %)
(As of 11/12/2019 02:21 PM ET)
Today's Range
$5.11
Now: $5.29
$5.57
50-Day Range N/A
52-Week Range
$1.67
Now: $5.29
$6.84
Volume6,881 shs
Average Volume137,132 shs
Market Capitalization$217.37 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company develops blood-based Nu.Q immunoassays to detect specific biomarkers. VolitionRX Limited is based in Singapore.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:VNRX
Previous SymbolNYSEMKT:VNRX
CUSIPN/A
CIKN/A
Phone646 650 1351

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees44
Market Cap$217.37 million
Next Earnings Date11/13/2019 (Confirmed)
OptionableNot Optionable

Receive VNRX News and Ratings via Email

Sign-up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter.


VolitionRX (NYSEAMERICAN:VNRX) Frequently Asked Questions

What is VolitionRX's stock symbol?

VolitionRX trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "VNRX."

How were VolitionRX's earnings last quarter?

VolitionRX Ltd (NYSEAMERICAN:VNRX) released its earnings results on Wednesday, May, 8th. The medical research company reported ($0.12) earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.12). View VolitionRX's Earnings History.

When is VolitionRX's next earnings date?

VolitionRX is scheduled to release their next quarterly earnings announcement on Wednesday, November 13th 2019. View Earnings Estimates for VolitionRX.

How can I listen to VolitionRX's earnings call?

VolitionRX will be holding an earnings conference call on Wednesday, November 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for VNRX?

2 brokerages have issued twelve-month target prices for VolitionRX's shares. Their forecasts range from $5.00 to $6.00. On average, they anticipate VolitionRX's share price to reach $5.50 in the next year. This suggests a possible upside of 4.8% from the stock's current price. View Analyst Price Targets for VolitionRX.

What is the consensus analysts' recommendation for VolitionRX?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for VolitionRX in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for VolitionRX.

Has VolitionRX been receiving favorable news coverage?

Media coverage about VNRX stock has trended very negative this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. VolitionRX earned a daily sentiment score of -3.2 on InfoTrie's scale. They also assigned press coverage about the medical research company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for VolitionRX.

Are investors shorting VolitionRX?

VolitionRX saw a increase in short interest in the month of October. As of October 31st, there was short interest totalling 441,000 shares, an increase of 43.1% from the September 30th total of 308,200 shares. Based on an average trading volume of 252,700 shares, the short-interest ratio is presently 1.7 days. Approximately 1.8% of the shares of the company are sold short. View VolitionRX's Current Options Chain.

Who are some of VolitionRX's key competitors?

What other stocks do shareholders of VolitionRX own?

Who are VolitionRX's key executives?

VolitionRX's management team includes the folowing people:
  • Dr. Martin Charles Faulkes, Exec. Chairman (Age 75)
  • Mr. Cameron Reynolds, Founder, CEO, Pres & Director (Age 48)
  • Dr. Jacob Vincent Micallef Ph.D., MBA, Chief Scientific Officer (Age 63)
  • Dr. Jason Bradley Terrell, Chief Medical Officer (Age 39)
  • Mr. Rodney Gerard Rootsaert LLB, Corp. Sec. (Age 48)

Who are VolitionRX's major shareholders?

VolitionRX's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Oppenheimer & Co. Inc. (0.03%). Company insiders that own VolitionRX stock include Cameron John Reynolds, Corp Ltd Eight, Guy Archibald Innes and Martin Charles Faulkes. View Institutional Ownership Trends for VolitionRX.

Which major investors are selling VolitionRX stock?

VNRX stock was sold by a variety of institutional investors in the last quarter, including Oppenheimer & Co. Inc.. View Insider Buying and Selling for VolitionRX.

How do I buy shares of VolitionRX?

Shares of VNRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is VolitionRX's stock price today?

One share of VNRX stock can currently be purchased for approximately $5.25.

How big of a company is VolitionRX?

VolitionRX has a market capitalization of $215.72 million. VolitionRX employs 44 workers across the globe.View Additional Information About VolitionRX.

What is VolitionRX's official website?

The official website for VolitionRX is http://www.volitionrx.com/.

How can I contact VolitionRX?

The medical research company can be reached via phone at 646 650 1351.


MarketBeat Community Rating for VolitionRX (NYSEAMERICAN VNRX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  171 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  315
MarketBeat's community ratings are surveys of what our community members think about VolitionRX and other stocks. Vote "Outperform" if you believe VNRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VNRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Featured Article: Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel